GSK Sells Indian Site To Hetero Labs

Company Strikes $25m Deal For Manufacturing Plant In Vemgal, Karnataka

sold property sign
GSK sells Karnataka plant to India’s Hetero Labs • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business